Skip to main content

Weill Cornell Medicine to help plan clinic in China

Weill Cornell Medicine has entered into an agreement with Top Spring Huaxia Medical Investment to help it develop a modern outpatient diagnostic clinic in Shenzhen, China.

Mechanism underlying cell stress response discovered

New Cornell research published online Nov. 9 in Nature Cell Biology describes a system that controls levels of a cell's sensors, which are responsible for detecting the accumulation of misfolded proteins.

'Super natural killer cells' destroy lymph node tumors

Cornell biomedical engineers have developed specialized white blood cells – dubbed "super natural killer cells" – that seek out cancer cells in lymph nodes with only one purpose: destroy them.

Summit shows taking risks drives success for entrepreneurs

At the Cornell Entrepreneurship Summit in New York City Nov. 6, CEOs presented, students pitched business ideas, and President Garrett and spoke of Cornell's entrepreneurial roots.

Lung test finds 'healthy' smokers at risk for COPD

A Weill Cornell Medicine investigators suggests a lung function test frequently to evaluate whether a smoker is at risk for developing pulmonary disease is likely mislabeling smokers as healthy.

Cornell teams join NSF campaign for cybersecurity

Six Cornell researchers will receive grants totaling more than $3 million as part of the National Science Foundation Secure and Trustworthy Cyberspace program.

Obesity leads to 'silent' vitamin A deficiency in organs

Obesity impairs the body’s ability to use vitamin A appropriately and leads to deficiencies of the vitamin in major organs, according to new research conducted at Weill Cornell Medicine.

New drug combo suggests promising lymphoma treatment

Weill Cornell Medicine finds a combination therapy lacking many debilitating effects manages mantle cell lymphoma, shrinking the malignancy and inducing remissions in most patients.

Cornell Tech Runway Program accepting postdoc applications

The Runway Startup Postdoc Program – described as "part business school, part research institution, part startup incubator" – is designed to advance the participants' research and launch new business ventures.